BDNF and schizophrenia: Low expression of NGF in prefrontal cortex and low levels of BDNF in hippocampus, measured in rodent models of schizophrenia, may indicate that they are associated with cognitive impairment during disease progress and its therapy with antipsychotic drugs [95].